DENVER, CO--(Marketwired - June 16, 2014) - CannLabs, Inc. (OTCQB: SDSPD), a leader in cannabis innovation, science and technology, has named Jon Merriman and Carl Banzhof to its newly formed Business and Technology Advisory Board. The board provides the CannLabs management team advice and guidance on best practices across a number of business and technology related areas. The board will play an essential role in shaping future business strategy as the company continues to expand its geographic footprint and service offerings.
As co-Founder and CEO of Merriman Holdings, Inc., Mr. Merriman is responsible for the overall strategic direction of the firm and focuses on working closely with the firm's clients. He actively advises the firm's fast-growing public companies on complex capital market and financing issues, and works with small cap, growth oriented investors. With more than 25 years of experience in the investment banking and brokerage business, he brings deep experience in corporate turnarounds and growing businesses. His extensive institutional and personal network and his trading experience give him a unique perspective when working with investment banking clients as well as institutional investors.
Prior to forming Merriman Capital, Mr. Merriman was Managing Director and the head of the Wells Securities (WFS) equity group, formerly First Security Van Kasper (FSVK), and served on FSVK's Board of Directors. As a result of a financing completed by WFS, he was appointed to the Board of Directors of Ratexchange Corporation, a publicly traded telecommunications company. He was subsequently appointed Chairman and CEO of Ratexchange, which he restructured into Merriman Curhan Ford, now known as Merriman Capital. Merriman Capital grew from six people and $1 million in revenues to over 200 employees and $90 million in revenues in 2007. Over the course of his finance career, he has served on more than 10 private and public company boards.
Mr. Merriman has been a frequent guest on Bloomberg TV as well as CNBC's show "Fast Money," and a regular contributor to financial publications such as The Wall Street Journal, Barron's and The Daily Deal. He is an active collector of emerging artists and served on the boards of the San Francisco Art Institute and the Santa Monica Art Museum. Merriman holds a B.A. from Dartmouth College and is based in the firm's San Francisco office.
Carl Banzhof is the CEO and co-founder of iScan Online, Inc. where he is responsible for the overall strategy and direction of the company. Prior to that, Mr. Banzhof was an executive with McAfee, Inc (Intel Security), where he held several positions including Vice President Technology Strategy, VP of Engineering for McAfee Avert Labs and VP Chief Technology Evangelist.
In his role as VP Technology Strategy, Mr. Banzhof chaired the McAfee Patent review board, led the global product security team and was the technology due diligence executive overseeing over $800 million in acquisition transactions. Prior to joining McAfee, Mr. Banzhof was the Chief Technology Officer and co-founder for Citadel Security Software, Inc, where he invented the automated remediation technology that McAfee acquired in 2006. A security industry veteran with 20 years of experience, Mr. Banzhof serves as an appointee to the Open Vulnerability Assessment Language (OVAL) Board and has also participated in federal government-led cyber security exercises including Cyber Storm I and II.
Mr. Banzhof is a frequent speaker at various security conferences and was named one of the Top 25 Most Influential CTOs by InfoWorld Magazine in 2005. Mr. Banzhof is the named inventor on four U.S. issued patents for security and compliance related technologies.
CannLabs, Inc., is a solutions provider with intellectual property, proprietary cloud-based analytics and scientific methods to serve the cannabis industry. Through Carbon Bond Holdings Inc., CannLabs provides laboratories with the necessary business intelligence technology and other solutions required to serve the cannabis industry, and these include the first state-licensed laboratory in Denver, Colorado.
CannLabs enables growers, dispensaries and edible makers to implement best practices while furthering product advancements. In addition, the CannLabs website allows consumers to easily locate certified tested products to meet their specific needs.
CannLabs has been at the forefront of educating the public, in addition to state and local governments as more states legalize marijuana for various uses. The Company provides client education around safe cultivation, identifying contamination problems, consulting on legal cases and the reformulation of cannabis products, throughout the U.S. and Canada.
The Company plans to license their solutions to new labs and other cannabis companies in states and provinces as legislation and testing mandates for legalization are approved. This will allow the Company to further scale its data analytics and consulting business across a broader geographic area. In addition, the CannLabs team will focus on research and development which will further drive value for their customers and provide incremental revenue opportunity.
Safe Harbor Statement
All statements herein other than statements of historical facts are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These statements are based upon our current expectations and speak only as of the date hereof. Such statements are not guarantees of future performance and are subject to known and unknown risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in such forward-looking statements. Such factors include, but are not limited to, our ability to raise additional capital, our limited operating history and revenue, our ability to attract and retain qualified personnel, our ability to develop new services, market acceptance of our services, legislative, regulatory and competitive developments in our industry, general economic conditions, as well as other factors set forth in our filings with the SEC.